Anti-Infection Tissue Engineering Construct Treating Osteomyelitis in Rabbit Tibia

2013 ◽  
Vol 19 (1-2) ◽  
pp. 255-263 ◽  
Author(s):  
Junchao Xing ◽  
Tianyong Hou ◽  
Bianba Luobu ◽  
Fei Luo ◽  
Qianbo Chen ◽  
...  
2011 ◽  
Vol 152 (1) ◽  
pp. 153-158 ◽  
Author(s):  
T. B. Bukharova ◽  
I. V.Arutyunyan ◽  
S. A. Shustrov ◽  
I. S. Alekseeva ◽  
I. A. Fedyunina ◽  
...  

2021 ◽  
Vol 19 (4) ◽  
pp. 343-349
Author(s):  
G. A. Volozhin ◽  
E. A. Bazikian ◽  
R. V. Deev ◽  
I. E. Bozo ◽  
E. A. Presnyakov

Relevance. The effect of a tissue engineering construct based on synthetic octacalcium phosphate activated with plasmid DNA with vascular endothelial growth factor gene on bone morphogenesis at the jaw defect sites of patients was studied. It is shown that the studied osteoplastic material stimulates osteosynthesis pathways already at early stages, and xenogenic hydroxyapatite, triggers osteogenesis processes with considerable delay and does not have time to form a full-fledged bone structure by 6 months.Aim. Evaluate the dynamics of reparative osteogenesis based on the results of histomorphometric diagnostics in patients with defects in the jaw bones of various configurations and lengths with an implanted bone matrix based on synthetic octacalcium phosphate activated with plasmid deoxyribonucleic acid with genes of vascular endothelial growth factor.Materials and methods. Histomorphological examination of bone tissue biopsy of jaws was carried out in 50 patients of both genders, who needed additional volume of bone tissue to install dental implantation. Patients were divided into 2 groups by type of grafted material. 6 months after the surgery, bone biopsies were taken from the bone sites at the stage of implant placement. Histomorphological patterns and histomycrophotograms were studied in bone biopcies.Results. In bone tissue biopsies of patients implanted with a tissue engineering construct based on synthetic octacalcium phosphate activated with plasmid DNA with vascular endothelial growth factor gene, it was revealed that after 6 months there was prevaluation of mature bone tissue (42,71%), with the proportion of differentiated plate bone tissue being < 90%.Conclusions. Histomorphometric analysis showed that in patients implanted with a tissue engineering construct based on synthetic octacalcium phosphate activated with plasmid DNA with vascular endothelial growth factor gene, after 6 months, early rearrangement of bone tissue into a mechanically dense and highly mineralized structure was detected. 


2015 ◽  
Vol 30 (6) ◽  
pp. 873-885 ◽  
Author(s):  
Mari Ainola ◽  
Waclaw Tomaszewski ◽  
Barbara Ostrowska ◽  
Ewa Wesolowska ◽  
H Daniel Wagner ◽  
...  

2018 ◽  
Vol 33 (14) ◽  
pp. 1939-1947 ◽  
Author(s):  
Samit Kumar Nandi ◽  
Gary Fielding ◽  
Dishary Banerjee ◽  
Amit Bandyopadhyay ◽  
Susmita Bose

Abstract


Author(s):  
Kivilcim Buyukhatipoglu ◽  
Wei Sun ◽  
Alisa Morss Clyne

Tissue engineering may require precise patterning of cells and bioactive factors to recreate the complex, 3D architecture of native tissue. These cells and bioactive components may then need to be repositioned during tissue growth in vitro and noninvasively imaged to track tissue development. We developed a new hybrid nano-bioprinting system by combining the initial patterning capabilities of a direct cell writing system with the active patterning capabilities of superparamagnetic nanoparticles. The iron oxide nanoparticles can be conjugated with proteins or loaded inside cells, printed into computer-defined patterns, and then manipulated and imaged within the 3D tissue engineering construct. In this study, iron oxide nanoparticles were bioprinted either in an alginate scaffold or inside endothelial cells. Cell viability, patterning, and imaging were assessed.


Author(s):  
Sheeny K. Lan ◽  
Daniel N. Prater ◽  
Russell D. Jamison ◽  
David A. Ingram ◽  
Mervin C. Yoder ◽  
...  

The natural healing process cannot restore form and function to critical size bone defects without the presence of a graft to support and guide tissue regeneration [1]. Critical size bone defects in humans are typically on the order of centimeters or larger [2]. Thus, a major limitation of synthetic grafts or bone tissue engineering constructs is the lack of vascularization to support cell viability after placement in vivo [3]. Cells that participate in bone regeneration, must reside within 150–200 microns of a blood supply in order to gain proper nutrients and to eliminate waste [4]. Consequently, a tissue engineering construct of a clinically relevant size cannot rely on diffusion for transport of nutrients and waste. Previous research has shown that blood vessels can infiltrate scaffolds, but the overall process is too slow to prevent death of cells located in the center of a construct [5].


Sign in / Sign up

Export Citation Format

Share Document